Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
This rising trend mirrors the evolution of the pharmaceutical industry in terms of investment and utilisation of novel ...
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...
The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...
The Food and Drug Administration has ignited a heated debate with its latest review of menthol cigarettes, revealing ...
Approval of Spravato, granted following FDA priority review, was based on the results of a randomized, double-blind, ...